Venn Biosciences Corporation
Latest round
- Series C
Last raised
- Aug 2021
Total raised
- $213M
Investors
- 12
About Venn Biosciences Corporation
Founded in 2017 and based in California, US, Venn Biosciences Corporation is building a liquid-biopsy solutions platform. The company was founded by CEO Aldo Carrascoso. The company utilizes a proprietary glycoproteomics biomarker interrogation platform using AI and mass spectrometry for next-gen precision medicine. Venn Biosciences is also working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression. The company is using AI-powered software for glycoprotein analysis, biomarker research, liquid-biopsy assay development, and new drug target discovery.
Who invested in Venn Biosciences Corporation
12 investors across 5 rounds
See all investors in Venn Biosciences Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Venn Biosciences Corporation
Who invested in Venn Biosciences Corporation?
Venn Biosciences Corporation has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Venn Biosciences Corporation raised?
Venn Biosciences Corporation has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Venn Biosciences Corporation last raise money?
Venn Biosciences Corporation's most recent round on record is a Series C, in Aug 2021.
What does Venn Biosciences Corporation do?
Founded in 2017 and based in California, US, Venn Biosciences Corporation is building a liquid-biopsy solutions platform.
Where is Venn Biosciences Corporation headquartered?
Venn Biosciences Corporation is headquartered in San Francisco, US.
Which VCs invest in companies like Venn Biosciences Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Venn Biosciences Corporation's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Venn Biosciences Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.